Investment Pitches

Pitch Summary:
APPN's platform allegedly facilitates Russian money laundering via Raiffeisen Bank. It's the only Western bank operating in Russia, reportedly lacks anti-money laundering controls.

BSD Analysis:
Appian provides a low-code development platform but trades at a premium valuation. Shorts highlight slowing enterprise adoption, rising sales costs, and the long sales cycle for large deployments. While the company has won litigation-related windfalls, core fundamentals remain challenged by competition from Microsoft PowerApps and ServiceNow. Cash burn continues, and profitability remains distant. Without accelerating adoption, APPN risks multiple compression as growth normalizes.

Pitch Summary:
@TechFundies argues that Adobe’s results were fine but do not shift the broader narrative: fundamentals remain solid but competitive/AI concerns cap upside. Adobe’s mature growth and margins imply valuation should rest on GAAP metrics, where downside appears larger than upside. AI revenue contribution remains too small to move the needle near term. Bulls highlight Adobe’s dominance in creative software and the potential for a future rerating, while bears focus on rising AI competition and macro uncertainty. Overall the author sees an unfavorable risk/reward setup until Adobe proves durable competitive positioning in an AI-driven landscape.

BSD Analysis:
Adobe operates in a mature, highly profitable segment of enterprise and creative software where valuation is increasingly driven by durability rather than optionality. Industry structure is shifting as generative AI lowers barriers to entry in image, video, and design tools, intensifying competition from both startups and scaled platforms like Canva. Adobe’s competitive moat remains its integrated, end-to-end creative suite, deep professional workflows, and brand-safe AI positioning, which supports retention at the high end of the market. However, AI monetization is still nascent and hard to disentangle from core subscription growth, creating skepticism around incremental TAM expansion. The key risk is not near-term execution but perception: if growth decelerates, investors may attribute it to secular erosion rather than macro, pressuring the multiple. Upside hinges on Adobe proving it can both defend seat pricing and meaningfully monetize AI at scale, which may take time. Until clarity improves, the stock appears fairly valued with asymmetric downside relative to upside.

Actual Post Content:
$ADBE put up in-line results / guidance. Story is moving sideways (fine fundamentals offset by questions about AI / competition) as are numbers. Risk / reward not attractive here. This is a company w/ mature growth and margins so should be valued on GAAP numbers. Downside of -28% to 18x CY25 street GAAP EPS, and -18% on CY26. Upside of 14% to 25x CY26 street GAAP EPS. Bulls would argue 30x is possible if it turns out they effectively navigate the new AI world but that certainty seems a long ways out to me. The quarter ADBE rev of 5.7b grew 11% yy cc w/ digital media rev of 4.2b up 12% yy cc (ARR exited at 13% yy cc) and digital experience rev of 1.4b up 10% yy cc. GAAP OM of 38%. AI contribution hit 125m exit run-rate and is expected to grow to 250m by year-end. This revenue consists of fees paid for Acrobat AI, Firefly, and GenStudio all of which were announced relatively recently. They believe this definition of AI is overly narrow as plenty of incremental subscribers buy Adobe partly for the AI features that are included in the core – but this would be very difficult to measure. An issue is that even ~200m AI rev contribution this year is <1% of total revenue so just not moving the needle at all. Bull case -ADBE is the strongest creative software player – most powerful and complete package of software -AI solutions are brand-safe and competitive. Will also be platform for other models as well. -Canva will remain at low-end, maybe more competitive with Powerpoint, and Adobe Express helps hold the line. -Growth + margin model persists which should allow for EPS growth in low to mid teens. -Multiple will rerate to 30x in the future when AI / competitive concerns dissipate Bear case -Many AI peers w/ compelling image / video generation. They will eat away at ADBE value prop and eventually seats. -Canva is dominant in low-end and w/ younger users. They also are incorporating AI functionality and will eat away at ADBE over time. -Macro getting worse. If numbers slow, will be impossible to know whether it is macro, competition, AI reducing TAM, or all 3. Investors shoot first, ask questions later. -Multiple can go much lower if secular / competitive concerns are priced in. GOOGL trades at 18x GAAP EPS for faster profit growth bc of AI concerns. ADBE currently trades at 25x... Notes Creative -Will have web firefly that supports external models as well and then provide pathway to full suite -Photoshop now avail on web and mobile app AI -Journey has 3 parts – innovate, track usage and ensure value / monetization -125m in exit AI in Q1 and will double by year end. This is pure AI rev – but also think that AI as part of offering is driving core seat packages. -Includes Acrobat AI Assistant, Firefly App/Services and Gen Studio -90% of paid users tried AI video -Will incorporate third party models too -Allow customers to create custom models -35% of Photoshop MAUs use GenAI, 30% of Lightroom MAUs use GenAI Other -Acrobat + Reader usage growing 23% yy -Acrobat monthly web users up 50% yy -Express added 6kn new businesses up 50% qq

URL: https://x.com/TechFundies/status/1901741232789041513

Pitch Summary:
@jupiters_string argues that Kohl’s Corporation (KSS) is deeply undervalued, trading at about $8 — far below what the author estimates as a liquidation value of $20-25 per share. He notes that previous bullish reports had valued the company closer to $20, but at those levels price had already declined significantly, making the current drawdown an attractive entry point. The pitch highlights Kohl’s considerable real estate portfolio (from hundreds of store premises), its inventory, and its balance sheet net of debt — all of which, he argues, create a base-case liquidation valuation well above current market price. He views this as a contrarian, value-oriented “ice-cube” thesis whose worst outcome is mitigated by conservatively valuing real estate and inventory, and whose upside could exceed 100%. The thesis is presented as a Bull case — a deep value bet rather than a growth or turnaround call. Key risks include execution, potential value traps, and the timing/realizability of the supposed liquidation value.

BSD Analysis:
Kohl’s remains a well-known national department store chain with substantial physical footprint and real estate holdings, factors which often serve as a floor under share value in distressed retail names. The author’s liquidation-based valuation argues the equity market is ignoring the embedded real estate and working capital value — not unreasonable for a bricks-and-mortar retailer with many stores. However, the liquidation-value approach presumes that real estate can be monetized at close to book value, inventories sold near cost, and debt obligations handled cleanly — assumptions that often prove optimistic, especially given retail-sector headwinds, lease obligations, and potential store-closure costs. Moreover, retail trends continue favoring e-commerce and omni-channel players; store-based chains like Kohl’s may struggle to realize full value absent a specialized buyer or aggressive restructuring. Operational risk is material: declining comparable-store sales, online competition, and weak consumer demand make liquidation a non-trivial outcome rather than a base case. Lastly, even if liquidation value is real, the time horizon and execution risk (valuing real estate, selling assets, dealing with stores and leases) could result in a long, value-destroying process before shareholders see benefit — during which discount rate, carrying costs, and business deterioration could erode much of the upside. In short: the thesis identifies a compelling asymmetric payoff, but realization depends heavily on both external conditions (real estate market, M&A interest) and aggressive, competent execution — making this more a speculative value play than a core long-term investment.

Actual Post Content:
“Kohl's Is Currently Trading Below Liquidation Value” was the title of a Seeking Alpha article published in January, when stock traded at $13.6. As high as $20, similar write-ups were circulated not long before the Seeking Alpha article. Each article put forth the investment archetype of a strong balance-sheet in a declining business (“melting ice-cube”) without obvious imminent catalyst. I usually pay little attention to these trades as they often extract a pound of flesh before resolving or are low IRR value traps, but I'm increasingly constructive in this instance. Today, the discount is all the deeper at the current price of $8 per share, and, I believe, comes at an increasingly opportune time for an entry. Recapitulating, Kohl's has $4-to-$8bn of real estate from several hundred premises (carrying value is understated due to depreciation accumulated), $1-to-2bn of inventories and c. $2bn of bond and bank debt inclusive of drawn RCF. This implies liquidation value of $20-25 per share, depending on the conservatives applied to valuing the real estate and inventories, presenting an opportunity of +100% of upside to the prevailing trading price. At $8 (1/3rd of lower bound fair-value) is this trade worth a shot? Jim Cramer doesn't think so, but I do for three reasons above and beyond the widening discount in recent weeks: First, timing of the recent sell-off in coincidence with a broader market panic prompting reallocation of capital from GARP or 'quality businesses' to ex-US value and, I venture, to smaller US companies (ex-S&P 100) - evidenced by an inability of the S&P 100 to outperform since the final quarter of 2024.

URL: https://x.com/jupiters_string/status/1901649431612506463

Pitch Summary:
Tenable is a top-three player—and the share leader—in vulnerability management, expanding into unified exposure management across on-prem, cloud, and OT. The Tenable One platform bundles VM, cloud, identity, and exposure analytics into a single pane, which is driving mix shift (20% of new business in 2023, ~40% in 2024). Recent acquisition of Vulcan Cyber adds remediation orchestration and 100+ third-party integrations, strengthening prioritization and workflow. Channel leverage (5,000+ partners and MSSPs) underpins efficient go-to-market and broad mid-market and enterprise reach. Despite macro caution and a conservative 2025 guide (public sector ~15% of sales), demand drivers remain durable given rising breach costs and hybrid IT complexity. Management projects strong incremental profitability; ex-deal, the core is adding revenue at ~52% incremental EBITDA margin with ~28% UFCF margin on the way to a 35% Bull-term goal. Versus Qualys’ best-in-class margins, Tenable’s trajectory suggests scope for operating catch-up and multiple re-rating. On company guidance (~$270M 2025 FCF), shares trade at ~6.3% forward FCF yield and ~4–4.3× EV/Sales, the low end of history. Relative to peers at higher multiples (and slower growth in some cases), the setup supports 50%+ upside if EV/Sales expands toward 6–7× with execution. Optionality from consolidation remains: all three VM leaders were approached in 2024, and TENB’s scale and valuation make it a logical target or acquirer.

BSD Analysis:
Leadership in VM with a credible extension to exposure management (platform + Vulcan) can sustain double-digit growth and operating leverage as the mix tilts to cloud and platform deals. Skeptic: Federal spending pauses and DOGE scrutiny on software waste could dent bookings velocity and eBullate deals despite security’s mission-critical status. Diligence: Track Tenable One ARR mix, NRR near ~110%, gross/EBITDA margin progression, Vulcan cross-sell, and federal pipeline conversion vs. guide. Valuation: At ~6.3% FCF yield and ~4–4.3× EV/Sales, a re-rate toward 6–7× on peer convergence and margin lift implies ~50% upside; downside cushioned by consistent beats since IPO and net cash (~$37M). Risks: Competitive intensity from QLYS, RPD, and cloud-native platforms; integration risk on Vulcan; macro/federal delays; SBC dilution. Catalysts: Upside to conservative 2025 guide, rising Tenable One contribution, improving margins, and potential M&A.

Pitch Summary:
Helix operates the world’s largest fleet of offshore well-intervention vessels, and tight market supply plus repriced contracts set up a step-function in earnings and FCF. The Well Intervention segment reset legacy day-rates higher (e.g., ~40% increases on Siem Helix I/II in Brazil and ~20% uplift on Q5000 in GoM), while transit downtime should fall in 2025. Robotics demand remains firm across O&G and renewables; day-rates for ROVs/trenchers are rising and the mix is diversified globally. Production Facilities provide contracted, cash-generative base load (Helix Producer I, Fast Response System) with optional upside from emergency response. Shallow Water Abandonment normalized after a 2023 spike tied to bankruptcy-driven P&A, but cost right-sizing and improving award cadence should restore $40–50M segment EBITDA at steady state. The balance sheet flipped to net cash (~$53M) after refinancing converts into 9.75% 2029 notes and paying the Alliance earn-out, giving HLX flexibility to accelerate buybacks. 2025 guide implies ~$1.36–1.50B revenue, $320–380M EBITDA, and $175–225M FCF—translating to a ~20% forward FCF yield at current prices. Management plans to allocate at least 25% of FCF to repurchases (min. $50M in 2025), highly accretive versus intrinsic value. On our sum-of-segments and DCF work, shares at ~3.5× 2025E EBITDA and ~0.8× P/TBV discount an unduly bearish cycle outcome. We see asymmetry: floor value analysis clusters near the stock price (~$7.6), while normalized through-cycle cash generation supports a path to mid-teens per share.

BSD Analysis:
Structural undersupply in well-intervention fleets, multi-year day-rate resets, and improving utilization create operating leverage across vessels and standalone tooling. Skeptic: A sharp oil/gas price downturn could pressure offshore activity, invite rig competition, or delay awards—especially in UK/North Sea. Diligence: Track vessel calendars (dry-docks, transits), Brazil contract execution, UK policy impacts, Robotics vessel charter pass-throughs, and Alliance utilization/cost actions. Valuation: ~3.5× 2025E EBITDA and ~20% FCF yield look compelling versus peers; DCF (12.5%/3.5% TG) supports ~$15–16 equity value with buybacks as a catalyst. Risk Management: Maritime ops, contract slippage, wind permitting pauses (limited direct U.S. exposure), and balance of fixed/charter costs remain key variables. Catalyst: Strong 2025 print/guide conversion to cash, accelerated repurchases, and any strategic alternatives headlines could unlock a re-rate.

Pitch Summary:
Steris is a high-quality healthcare sterilization and infection prevention company that has lagged the broader market since 2021 despite strong fundamentals. Reported growth in FY24–25 was obscured by temporary factors: the sale of its low-growth Dental business, a one-time $5M contract loss in AST, $20M in EtO litigation expenses, and elevated corporate overhead. With those headwinds largely behind it, FY26 (starting April 2025) should mark a return to Steris’s Bull-term algorithm of low-teens EPS growth and stable margin expansion. The core AST (Applied Sterilization Technologies) segment—~35% of profits—appears poised for double-digit organic growth as hospital destocking and bioprocessing weakness fade, with incremental margins around 60%. The EtO litigation overhang has materially eased following a $48M global settlement of Illinois cases and favorable peer verdicts, removing a key valuation drag. Corporate costs, which ballooned to 7.2% of sales, are now a focus area for restructuring and could see rationalization in FY26. A more favorable cost and litigation backdrop plus easing bioprocessing headwinds position Steris for margin normalization and reacceleration in earnings. Trading at ~21.5× FY26 EPS of $10.50, the stock sits below its historical mid-20s multiple despite 10–12% compounding potential and a 1% dividend. Over time, the business should deliver mid-teens total returns as growth normalizes and investor confidence returns. Risks include tariff exposure from Mexico/Canada and a conservative near-term guide, but the Bull-term setup offers a clean re-rate opportunity.

BSD Analysis:
High recurring revenue, strong pricing power, and dominant sterilization share underpin a durable mid-teens ROIC business; FY26 earnings should benefit from fading one-offs and restructuring savings. Skeptic: Margin expansion in AST assumes bioprocessing recovery and energy normalization—both could lag if hospitals restock slower or Europe weakens. Diligence: Monitor EtO litigation updates, tariff developments, and incremental margin progression; review restructuring disclosures for cost savings timing. Valuation: At 21–22× forward earnings, Steris trades modestly below premium peers despite higher predictability and balance sheet strength. Catalyst: FY26 guide should show acceleration post one-offs, while legal clarity and cost control reestablish investor trust. Bull-term: The business’s recurring sterilization economics and clean balance sheet support sustained FCF compounding with optional M&A upside.

Pitch Summary:
Asaka Industrial is a 364-year-old Japanese nanocap manufacturer of gardening tools and logistics equipment trading at a deep discount to its underlying assets. The company’s market cap of ~¥1.5B ($10M) sits far below its net current asset value (¥2.5B) and securities investments (¥1.6B), together exceeding ¥4.1B or roughly ¥4,200/share versus a stock price of ¥1,600. Real estate owned near Osaka and Hokkaido—carried at book from decades ago—could be worth over ¥1.8B on today’s market prices, potentially bringing intrinsic value to ~¥6,200/share. The business has been steadily profitable for years, with earnings of ¥315/share in FY2024 (P/E ~5×) and a modest ¥30–50/share dividend (≈3% yield). It holds the #1 domestic market position in shovels and high-quality “Made in Japan” tools, serving a mostly domestic customer base insulated from FX volatility. Insiders and affiliated entities own roughly one-third of the shares, aligning incentives but dampening activist potential. Governance reforms sweeping Japan have spurred re-ratings of sleepy microcaps, improving prospects that Asaka could close part of its value gap through higher payouts, buybacks, or real-estate monetization. Liquidity is thin and the stock is suitable only for patient, Bull-horizon investors or as part of a small-cap value basket. Even conservative asset marks imply 2–3× upside potential from current levels, with limited downside given cash, investments, and property coverage. The setup offers exposure to Japan’s corporate reform theme through a tangible asset-rich, cash-generating niche manufacturer.

BSD Analysis:
Strong balance sheet with assets >3× market cap, consistent profitability, and steady dividends provide margin of safety in an illiquid market. Skeptic: Family/affiliate control and low liquidity may delay catalysts; asset unlock could remain theoretical without outside pressure. Diligence: Verify land appraisals via municipal registries, check unrealized securities values, confirm dividend continuity, and track governance disclosures for TSE compliance. Catalyst risk: Japan’s governance reforms (TSE pressure on low P/B firms) may nudge management toward capital efficiency, but execution could be slow. Counterpoint: Even if value-unlock takes time, investor downside is cushioned by NCAV and hard assets with little leverage. Macro tailwind: As reforms deepen and domestic retail participation grows, neglected nanocaps like Asaka may see multiple expansion simply via awareness.

Pitch Summary:
Solaris acquired MER. MER's co-owner has a history of environmental crimes and was involved in a prior scandal related to gas turbines. The acquisition involved significant financial commitments, including cash, stock, and debt repayment, raising questions about Solaris's strategic direction.

BSD Analysis:
Seitel (if ticker SEI refers to Seitel, an IT/data provider; alt. interpretation could be SEI Investments [SEIC], but assuming short sheet has SEI listed separately). The short thesis emphasizes niche positioning, customer concentration, and valuation above fundamentals. With limited growth levers compared to broader IT service providers, SEI faces downside risk if revenue growth stalls or contracts are repriced lower.

Pitch Summary:
Pyxus International is a 150-year-old global value-added tobacco processor operating in a duopoly with Universal Corp (UVV). The company sources, processes, and supplies flue-cured, burley, and oriental tobacco to cigarette manufacturers across Africa, Asia, and Europe, with demand remaining steady internationally. Recent El Niño pressures reduced crop yields and inflated input costs, but normalized weather should restore margins in FY25. Management guides to ~$210M FY25 EBITDA and ~$145M unlevered FCF, equating to a 14% ULFCF yield and 39% levered FCF yield on current equity. Despite improving fundamentals, shares trade at only ~5× EV/EBITDA versus UVV’s 8.8×, mainly due to legacy leverage and expensive debt (~13.5% term loan). Debt paydown in 2024 and expected refinancing could cut interest costs by ~40%, potentially doubling FCF per share from ~$1.70 to >$3.20. Institutional backers Monarch, Glendon, and Owl Creek control ~90% of equity and the board, aligning capital discipline and optionality for a refinancing or sale. With net debt of ~$960M and consistent deleveraging, each turn of EBITDA adds roughly $8/share in equity value. A rerate to 6.5× EV/EBITDA (vs. UVV 8.8×) plus $150M debt reduction implies $20+ fair value, ~4× upside from $4.30. The stock trades OTC with limited liquidity, creating inefficiency but offering asymmetric risk/reward as cash generation improves.

BSD Analysis:
Tobacco duopoly economics, recovering crop margins, and falling leverage underpin FCF compounding and valuation convergence with UVV. Skeptic: High leverage (~4.6× ND/EBITDA) and reliance on refinancing create balance-sheet fragility if credit conditions tighten. Diligence: Verify forward crop pricing, inventory levels, working-capital usage, and timing of debt amortization; monitor CFO replacement progress. Valuation: At ~5× EBITDA, each multiple turn adds ~$8/share; normalized interest savings (~500bps) double FCF to ~$3/share. Catalysts: Debt paydown, improved margins post-El Niño, refinancing at lower cost, or strategic sale/uplisting. Risks: Weather shocks, emerging-market exposure, limited trading liquidity, and OTC governance opacity.

Pitch Summary:
JPMorgan Chase is positioned as a cornerstone of the financial system, having played a crucial role during the Global Financial Crisis by acquiring Washington Mutual and Bear Stearns. The bank's ability to generate income from low-cost deposits and its significant market presence make it a safe investment. Despite the complexities of its financials, JPMorgan's scale and influence in the banking sector provide a strong foundation for future growth.

BSD Analysis:
JPMorgan Chase's strategy of leveraging low-cost deposits to originate loans is a key driver of its profitability. The bank's substantial deposit base of $2.4 trillion, compared to $866 billion in cash and short-term equivalents, underscores its ability to manage liabilities effectively. This structure allows JPMorgan to capitalize on interest income, a critical revenue stream for banks. The firm's historical resilience, demonstrated by its acquisitions during the financial crisis, highlights its strategic importance and stability. CEO Jamie Dimon's leadership and the bank's conservative risk management practices further enhance its investment appeal. While the banking sector faces regulatory and economic uncertainties, JPMorgan's robust capital position and diversified operations provide a buffer against potential market volatility. Investors should consider the bank's long-term growth prospects, supported by its strong balance sheet and strategic acquisitions, as a compelling reason to maintain a bullish outlook.

Pitch Summary:
Accel operates and services video gaming terminals (VGTs) in non-casino venues (bars, restaurants, truck stops), taking a contractual revenue split with host locations and the state. Per-unit economics are attractive: VGTs cost roughly $20–30k to deploy and typically generate ~$100k+ annual NTI, with operators keeping ~30–40%, implying fast paybacks and high ROIC. Growth comes from more licensed locations, more machines per location, higher wager limits over time, and bolt-on M&A in a fragmented market; ACEL holds ~1/3 share in Illinois and is expanding in MT/NE, with optionality in NV/LA. The business has compounded revenue >20% CAGR over a decade with stable margins; forward growth looks MSD top-line and MSD-HSD FCF as scale spreads fixed costs. Regulatory tailwinds include gradual state legalization and periodic increases to wager limits (e.g., MT proposal to lift $2 to $4 wagers). A new leg is the Illinois Fairmount racino project: a phase-one temporary casino in 2025 (255 machines) and a permanent casino by 2027 (~600+ slots, 24 tables) targeting ~$25m EBITDA and ~16% IRR. Contracts with locations are Bull-dated and splits are stable by statute, supporting visibility. Shares trade ~10x 2025 EPS, a discount to quality, growth, and private-market M&A multiples. With steady MSD EPS growth and de-risked racino execution, a 15x multiple is reasonable. Consolidation (accretive deals) and additional state legalizations are upside levers.

BSD Analysis:
Scale leader with sticky, statute-defined rev shares, short paybacks, and a Bull runway from new locations, more machines/location, wager-limit increases, and state-by-state adoption; steady MSD growth plus racino adds a new profit stream with ~16% IRR. Skeptic: Macro sensitivity of low-ticket gaming, potential tax hikes or split changes, competitive pushback from casinos, and racino timing/budget risk. Diligence: Track Illinois location count/VGTs, per-machine NTI trends, renewal terms and churn, state legislative calendars (legalization, split/tax changes, wager limits), and racino capex/timeline vs. plan. Valuation: ~9.9x ’25 EPS and low-teens implied FCF yield vs. MSD growth argues for re-rating toward 13–16x; every 1x P/E ≈ ~$1 per share. Catalysts: 1) Fairmount phase-one opening and ramp, 2) accretive tuck-ins at private-market multiples, 3) legalization or rule changes expanding TAM, 4) continued buybacks/FCF conversion. Risks: Regulatory shock (tax/split), project delays/cost overrun, recessionary NTI dips, and intensifying competition in NV/LA.

Pitch Summary:
@persistencecap argues that Samhi Hotels is mispriced due to broad selling pressure despite strong assets, quality brands, reasonable valuation metrics, and manageable debt. They highlight ~5,000 rooms under Marriott/Hyatt, strong growth visibility from new keys and rebranding, and refute potential bear cases regarding governance, brands, liquidity, and debt structure. The author sees the company as a fundamentally sound and undervalued hotel asset owner caught in a macro-driven small-cap selloff.

BSD Analysis:
The Indian hotel sector benefits from favorable long-term demand trends driven by domestic travel growth, corporate travel recovery, and limited high-quality room supply in key markets. Samhi’s asset-heavy model, combined with globally recognized brands, positions it well to capture operating leverage as occupancy and rates normalize. Industry structure favors scaled owners with diversified portfolios, reducing asset-level volatility compared to single-city or airport-heavy peers. The main risk lies in sentiment rather than fundamentals: in a prolonged bear market, leveraged asset owners and small caps can remain discounted regardless of intrinsic value. Short-term overhangs, such as lock-up expiries, may also pressure the stock. However, debt appears well-structured with no near-term refinancing cliff, and cash flow coverage of interest is healthy. If market conditions stabilize, valuation could re-rate toward peer EV/key multiples or closer to replacement cost, offering meaningful upside. The setup is asymmetric but requires patience, as near-term price action may remain volatile despite improving fundamentals.

Actual Post Content:
As the bear market rages on, we believe that the proverbial baby is being thrown out of the bathwater. The recent sell-off has been indiscriminate and businesses operated by savvy management teams that have both an attractive near-term setup and long growth runway are available at mouthwatering valuations. Today we’ll discuss one such position from our portfolio – Samhi Hotels. Full disclosure: we are invested and biased. If markets remain weak, this stock will likely go lower before it goes higher. Please do not treat this thread as an investment recommendation. We are simply surfacing ideas that we think are mispriced and trying to spread some optimism during holi. DYOD and consult a financial advisor before investing in any financial instrument. Samhi Hotels owns hotels assets comprising of ~5,000 operational rooms largely under the Marriott, Hyatt brands. It is important to note that Samhi is a not a franchisee to these brands. Instead, it enters management contracts with these brands where they are responsible. So is Samhi cheap? We can run this analysis in 3 different ways. The first one is on a replacement cost basis i.e. EV/key. Samhi has ~5,000 operational keys and ~700 new keys under development even if one excludes the disputed project in Navi Mumbai. Assuming zero value. We often hear that Indian multiples are elevated relative to global comps so we compared Samhi’s valuation on EV/EBITDA basis to asset heavy hotel businesses such as hotel REITs in the US. Per Factset, US hotel REITs trade at a median ~10x NTM EV/EBITDA. In comparison, Relative comparisons are ultimately meaningless and what matters is whether Samhi is cheap in absolute terms. Per Ambit estimates, Samhi trades at ~18x FY26 PE and ~12x FY27 PE - reasonable in absolute terms. As Munger would say, “invert always, invert”. So let’s invert and ask ourselves what Mr. market could be rightly worried about? Does Samhi trade at a discount to peers because it does not own the underlying brands but instead is an asset owner? Plausible argument except Juniper and Chalet do not own the underlying brands and their hotel portfolio is valued at ~200-500% premium on an EV / key basis. Are Samhi’s earnings disproportionately reliant on a few hotel assets that are exposed to a demand-supply imbalance? This can often be the case with hotel assets that are proximate to airports. While this is a legitimate concern for Chalet and Juniper as both have marquee. Are Samhi’s brands weaker than peers? Over 95% of Samhi’s keys are Marriott or Hyatt branded. Both these brands are objectively stronger than the Park brand and yet Samhi trades at a discount to Apeejay Surendra Park on a EV / key basis. In fact, we think Samhi’s brands. Are there corporate governance concerns or management quality issues with Samhi’s C-suite? Quite the opposite. Samhi was founded by Ashish Jakhanwala who scaled Accor’s India business before raising capital from Goldman Sachs and a bunch of other marquee investors to build. Is the stock illiquid? Given that management owns 2x its annual interest expense so the business would have to. Is there a large pre IPO lock-up that expires imminently? ~5% of Samhi’s free float will exit lock-up later this month. One can only hope that INR 150 cr of paper supply, in a hotel business trading below replacement cost with growth visibility both near term and medium. Is there visibility of near-term earnings growth? Investors hate uncertainty in a bear market and businesses with weak near-term earnings visibility are unlikely to catch a bid. Even if one disregards Samhi management’s in recent investor conferences or TV interviews. Is Samhi in the penalty box because it’s a “small cap”? We think so as market pundits have oft late pointed out that we should sell small caps “lock, stock and barrel” to load up on large caps or hybrid funds

URL: https://x.com/persistencecap/status/1900439695970246664

Pitch Summary:
@NestBetter (TechStockFundamentals) argues that Mattr is deeply undervalued, especially after a rough patch — estimating the company now trades at ~8.8× 2025 earnings and an EV/EBITDA around 5×. The thesis is that Mattr’s topline should grow roughly 10% over the medium term, and margins will expand toward 20%+ EBITDA as the company exits a large capital-expenditure cycle and ramps utilization of newer, more automated facilities. They also highlight that recent steel tariffs could benefit Mattr’s composite and fiberglass-based products (e.g. Xerxes, Flexpipe), giving them a relative advantage vs. steel. While acknowledging some tariff-related risk, the author believes Mattr has flexibility to shift production to lower-cost jurisdictions if needed. In sum, the pitch is a bullish “turnaround + re-rate” bet: from trough business conditions toward a much higher valuation multiple — potentially targeting a share price near “$50 in 5 years.”

BSD Analysis:
Mattr Corp. is a materials-technology firm serving energy, infrastructure, water, and industrial markets via composite pipes, fiberglass tanks, and related solutions. The company’s value-recovery case hinges on demand rebound in energy/infrastructure, sustained advantage of composites under tariffs, and improved utilization of recently built automated plants — factors that could unlock improved margins and re-rate the stock. Historically profitability has been weak, with low ROIC, inconsistent earnings, and only modest returns even when operating cash flow is positive. Cyclicality in end markets (oil & gas, construction, infrastructure), commodity-price volatility, and global supply-chain or tariff uncertainty pose meaningful downside. While the “$50 in 5 years” outcome is possible under bullish infrastructure and macro scenarios, execution and market-cycle risk make this a high-volatility materials-equipment play rather than a stable value compounder.

Actual Post Content:
$MATR.TO while I bike: Great outlook and guide After today we're, 8.8x '25 earnings. Topline will grow ~10% over the medium term Margins only going higher from here (heading to 20%+ ebitda) The only potential ST hair left is tariffs 1/x The tariffs enacted so far benefit them, steel tariffs make their composite products relatively more attractive (Xerxes, flexpipe). Worse case even if we get long lived broad tariffs they have plenty of room to shift production lines south w/ the new facilities. Business has bottomed and we have a perfect 3 trough setup exiting a large capex cycle: Tough macro end market (weak autos / well completions) Trough multiple 8.8x earnings, 5ishx ev/ebitda Trough margins Won't shock me if this is a $50 stock in 5 years.

URL: https://x.com/nestbetter/status/1900719470185775602$s=43&t=pQIybbYGPwfAIRjp-OZu8w

Pitch Summary:
Latham (SWIM) is a leading North American pool products maker with #1 share in fiberglass (FG) in-ground pools (~50%) plus meaningful covers and liners businesses. The pool cycle appears at/near a trough: new pool starts are ~6% of single-family starts vs ~11% Bull-term, pool financings collapsed, and R&R has been in a rare multi-quarter contraction. As rates ease and housing/R&R thaw, management guides 2025 revenue $535–565m (+8% y/y) and EBITDA $90–100m (+19%), driven mostly by share gains and tuck-ins even on flattish end-markets. FG pools are a secular share gainer versus concrete/vinyl due to faster installs and lower lifetime cost; FG share rose from 16% (2019) to 23% (2024) and has headroom (EU 35–50%, Australia ~70%). SWIM’s mix shift to higher-margin, direct-to-builder FG supports mid-cycle EBITDA compounding in the low-teens. Balance sheet is manageable (~2.4× 2025e EBITDA) with a path to ~2× and potential to ~1.5× by 2026–27 as EBITDA recovers. A return to ~78–80k U.S. pool starts implies ~$160m company guide, author estimates ~$180m 2027 EBITDA (vs ~$95m NTM). On normalized capex, FCFE could approach ~$0.85–$1.00/sh in a recovery, versus ~$0.30 in 2025. A re-rate to building-products multiples (15–20× forward FCF/sh) implies ~$15–$20 per share (vs $7). Risks include execution on growth/M&A, slower housing recovery, and regulatory or financing frictions.

BSD Analysis:
Cycle looks washed-out (attachment rate at record low), with multiple leading indicators turning; SWIM is the scale FG leader in a secular share-gaining category, creating self-help growth even in a flat market. FG’s cost/maintenance edge versus concrete/vinyl plus higher margins and direct sales should expand mix and profits through the cycle. Skeptic: Housing/R&R rebound could disappoint; pool starts might lag single-family if households remain rate-locked; FG adoption could slow if builders face labor/permit bottlenecks. Diligence: Track weekly mortgage rates, existing-home sales, R&R trackers, pool permit data, and dealer backlog; monitor FG lead times, price/mix, and liner replacement cadence. Valuation: At ~$7, SWIM trades ~11× NTM “owner earnings” with a path to ~5–6× on 2027 recovery EBITDA; peer re-rating case to 15–20× FCF supports $15–$20. Catalysts: Falling rates, improving pool starts/R&R, FG share gains, tuck-in M&A, deleveraging. Risks: Project delays, cost inflation, distributor/channel health, or a double-dip in housing.

Pitch Summary:
Garrett Motion (GTX) is a global leader in turbochargers (TBs), operating an entrenched duopoly with BorgWarner (BWA) in a highly technical, mission-critical component of internal combustion engines. Despite durable margins, high renewal rates, and multi-year visibility, the stock trades at ~5× FCF as investors over-discount its exposure to the declining ICE market amid BEV adoption. The turbocharger business is effectively locked in years ahead, with 90% of revenue booked 3+ years out and near-100% renewal rates. GTX generates ~$600M EBITDA with ~2× leverage and converts over half to FCF after maintenance capex, while using cash to aggressively repurchase shares—down one-third since 2022. Bears underestimate the stickiness of GTX’s commercial and aftermarket revenue (~40% of EBITDA) and overstate BEV cannibalization, which is moderating as EV penetration growth slows. GTX is investing ~$165M annually in zero-emission vehicle (ZEV) R&D and capex, currently a ~$130M drag on FCF, implying normalized “owner earnings” of ~$2.30/sh versus ~$1.65 headline. Even partial success in electrified turbo and fuel-cell air management (GTX’s ZEV technologies) could offset 50% of ICE EBITDA at risk by 2030. Under conservative assumptions, GTX can generate $1.5B cumulative FCF by 2030, retire ~50% of shares, and reach $3.50–$5.00/sh in FCF, while BEV disruption risk diminishes. If BEV penetration slows or ZEV wins materialize, a re-rating to 10× EPS (peer average) implies $17/share, nearly 90% upside. The setup offers deep value, buyback leverage, and embedded optionality on ZEV success.

BSD Analysis:
GTX has a moat-rich duopoly in turbochargers with sticky OEM relationships and high technical barriers; ICE-to-BEV transition fears overdone as BEV growth moderates and GTX’s 40% non-ICE EBITDA remains resilient; ongoing buybacks and ZEV optionality provide asymmetric upside. Skeptic: BEV penetration could accelerate faster than modeled, shrinking ICE TAM faster than GTX can diversify; R&D drag persists Buller, delaying FCF inflection. Diligence: Monitor global auto production trends, BEV mix shifts, OEM design wins, ZEV program progress and commercialization milestones; review share repurchase cadence vs. leverage. Valuation: 5× FCF (~20% yield) vs. peers ~9–10×; $17 PT at 10× 2025 EPS implies 90% upside; downside cushioned by buybacks and 2× leverage. Catalysts: 1) OEM share gains, 2) slower BEV adoption, 3) visible ZEV milestones, 4) continued buybacks, 5) auto production recovery. Risks: Cyclical auto downturn, FX headwinds, faster BEV mix, or R&D execution missteps.

Pitch Summary:
IQVIA Holdings Inc. is currently undervalued, trading at near all-time low valuation levels. The company has strong secular growth drivers, diverse capital deployment options, and high ROICs, which support its long-term EPS and FCF growth potential. Despite market concerns, IQVIA's fundamentals and historical premium trading relative to the S&P 500 suggest it is undervalued.

BSD Analysis:
IQVIA's formation through the merger of IMS and Quintiles in 2016 has proven synergistic over time, enhancing its market position. The company's current valuation at 15x NTM P/E is historically low, especially given its robust growth prospects and operational efficiencies. The CRO industry's consolidation and maturity may temper growth rates, but IQVIA's strategic initiatives and capital deployment strategies position it well for future success. The market's broad sell-off in life sciences has led to valuation dislocations, and IQVIA, with its strong growth drivers and historical trading patterns, represents a significant investment opportunity. Its ability to capitalize on outsourcing trends and leverage its global presence further underscores its potential for long-term value creation.

Pitch Summary:
@jaysyoon presents a highly bullish thesis on Hallador Energy centered on an imminent datacenter power contract. The pitch argues that undisclosed MISO filings and satellite imagery together strongly indicate a pending 620MW datacenter deal. Such a contract would lock in most of Hallador’s generation capacity for over a decade, fundamentally reshaping earnings power. The author projects an immediate re-rating to $15+ upon announcement, followed by a multi-year ramp driving shares to $45+. Financially, the deal is modeled to generate roughly $129m in annual net income and over $3 in EPS by FY 2027. Regulatory risk is framed as low due to the deal’s front-of-the-meter structure and minimal grid impact, supporting a bullish, asymmetric setup.

BSD Analysis:
Hallador represents a levered way to play rising datacenter-driven power demand, particularly in constrained regional grids. The core attraction is long-duration contracted cash flow that would materially reduce earnings volatility and reframe the company from merchant coal exposure to infrastructure-like power supply. Front-of-the-meter structuring lowers regulatory friction relative to colocation deals, but execution risk remains until contracts are fully signed and disclosed. Concentration risk increases meaningfully if a single datacenter absorbs most generation, raising counterparty and renewal considerations. Coal asset perception may still cap terminal multiples despite improved earnings visibility. If the deal closes on expected terms, however, the magnitude of incremental EBITDA and duration could justify a substantial re-rating even under conservative valuation assumptions.

Actual Post Content:
I have just released a bullish report on @HalladorEnergy. Based on 1) an undisclosed EPR filing to MISO, and 2) satellite imagery of ongoing excavation work at the proposed datacenter site, $HNRG is close to signing a transformative power deal for a massive 620MW datacenter. I believe a deal announcement is imminent, and could occur this coming Monday, March 17th when the Co reports its Q4 earnings. After a deal is announced, I expect HNRG shares to immediately re-rate by >50% to $15+. Over the next two years, once the datacenter is fully ramped up, I expect HNRG shares to increase by >400% and reach $45+. In addition to the EPR filing, my conclusion that $HNRG is close to signing a datacenter deal is further supported by satellite imagery. This imagery shows that excavation work near the proposed site began in late 2024 and has continued through the early parts of this year. The impact of a datacenter deal on $HNRG’s financial performance will be transformative. The proposed 620MW datacenter will contract most of the Co’s generation capacity for 10+ years, driving annual net income to an estimated $129m and EPS to $3.03 by FY 2027. By applying a conservative 15x multiple, I project HNRG shares will increase by >400% and reach $45+ over the next two years. The risk that $HNRG's datacenter deal will face significant regulatory delays or issues is low. Unlike the highly scrutinized colocation deals that are being aggressively pursued by $VST, $TLN and $CEG, the HNRG deal will be structured as a conventional front-of-the-meter transaction. As discussed by VST management during its Q4 earnings call, FTM arrangements are very common in the industry and “straightforward” to execute. Additionally, the $HNRG deal should have a minimal impact on the grid in terms of reliability and cost, further increasing its approval odds. The Merom plant operates at a capacity factor of just ~40%. This means the proposed datacenter would primarily utilize the ~60% of the plant’s output that currently goes unused. Additionally, the site’s close proximity to the plant limits the need for extensive infrastructure, with grid upgrades estimated at just $12.8m.

URL: https://x.com/jaysyoon/status/1900175501542769103

Pitch Summary:
TriMas (TRS) is a diversified manufacturer with three largely independent units—Packaging (~55% of revenue), Aerospace (~35%), and Specialty (~10%)—trading well below its sum-of-the-parts value. Activists Barington Capital and Trend International (~12.5% stake) have pushed for a breakup or sale after years of underperformance and structural complexity. A strategic review is underway following CEO turnover and Trend’s board appointment, with a sale of one or multiple divisions likely. SOTP analysis suggests 60%+ upside to ~$38/share, valuing Packaging at 9–11x EBITDA (vs comps Silgan ~9.5x, Aptar ~13x), Aerospace at 12–14x (vs peers Circor/Kaman takeouts ~13x), and Specialty at 6x. Packaging benefits from stable consumer end-markets (beauty, food, life sciences) and GDP+ growth; Aerospace from multi-year OEM backlogs and a new Airbus fastener contract that could grow its share to ~20%. TRS exited energy and low-margin industrials, improving quality of earnings and focus. Recent 25%+ growth in beauty/personal care and 22% Aerospace YoY underscores the rebound. Management targets 100–200bps of margin expansion in both Packaging and Aerospace by FY25–26 as efficiency investments normalize. Tariff risk exists but is partly offset by passthrough mechanisms covering ~60% of revenue and potential activist-driven value realization. At 6–7x blended EBITDA, TRS trades far below peer averages, offering attractive risk/reward whether as a standalone compounder or breakup candidate.

BSD Analysis:
Deep discount to SOTP amid activist pressure and a live strategic review; segments in strong end-markets (consumer packaging, commercial aerospace) with pricing power and high barriers to entry. Trend International’s board presence and CEO transition improve odds of divestitures or a premium sale. Strong tailwinds—Airbus contract, CPG customer gains, and industrial recovery—support revenue and margin upside. Skeptic: Execution risk around M&A integration, inflation lags, and tariff impacts; historical margin volatility raises credibility concerns. Diligence: Track timing/outcome of strategic review, Airbus ramp, packaging 4cc dispenser rollout, and pricing recovery vs input costs. Valuation: SOTP implies ~$38/share at 9–13x segment multiples; even partial realization of activist plan could yield 40–60% returns. Catalysts: Segment sale, strategic review outcome, continued Aerospace growth, and activist engagement updates. Risks: Macro slowdown, tariff escalation, slower Airbus ramp, or activist fatigue.

Pitch Summary:
X-FAB is a specialty analogue foundry (Europe/US/Malaysia) leveraged to auto/industrial semis that have been in a two-year downcycle. Management is finishing a ~$1.1B capex program by mid-2025, funded partly by ~$300M of customer prepayments and LTAs, which should lift earnings power as demand normalizes. Shares trade well below recent invested capital and at ~4x 2025 trough EV/EBITDA (3.3x vs 2023 peak), with the new capacity implying ~2–2.5x EV/EBITDA two years out. Q4’24 revealed over-shipping under LTAs; XFAB relaxed offtake to help customers work down inventory, pushing the automotive bottom into 1H–2H’25. Industrial/medical are improving; auto should recover into H2 per largest customer Melexis, while higher-value 200mm lines remain tight. Leverage should peak <1.5x ND/EBITDA in Q2’25, FCF inflects positive in H2’25, and management telegraphs dividends in 2026 (buybacks less likely). CEO (≈25% owner) keeps a low profile; free float ~40% contributes to mispricing. Geographic footprint localizes supply (EU/US/Asia) and brings subsidy tailwinds (EU programs; potential CHIPS). Tariff headlines and European OEM angst create volatility, but content per vehicle keeps rising high-single to low-double digits, supporting secular growth. Author sees 4–5x upside as cycle turns and the capex begins to earn.

BSD Analysis:
Auto/industrial destock is late stage; content per car rising and 200mm/180nm analogue nodes are capacity-constrained, so utilization/mix should improve as $1.1B of fresh tools ramp. Valuation is extreme vs peers (Hua Hong/Tower/Vanguard on ~6–13x) and vs XFAB’s enhanced earnings power—implying deep multiple/earnings catch-up. Skeptic: China analogue foundries could undercut over time; Melexis concentration, depreciation step-ups post-capex, and prior LTA over-shipments risk further estimate resets. Diligence: Track Melexis inventory/guide, XFAB 200mm vs 150mm loading, price-downs, subsidy awards, and cash conversion vs depreciation (sell side likely too low on D&A). Catalysts: H2’25 FCF inflection, completion of capex, auto order recovery, 2026 dividend initiation, potential strategic interest. Risk-mitigants: diversified fab footprint (US/EU/MY), local manufacturing vs tariff risk, and management/owner alignment (CEO buying shares).